Skip to main content
. 2021 Apr 30;2021(4):CD013257. doi: 10.1002/14651858.CD013257.pub3

1.21. Analysis.

1.21

Comparison 1: Single immunecheckpoint inhibitors vs chemotherapy, Outcome 21: HRQoL‐QLQC30‐change from baseline at week 15 ‐deterioration ‐ PDL1≥50%